- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Diagnostic Radiopharmaceuticals & Contrast Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Diagnostic Radiopharmaceuticals & Contrast Media size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Diagnostic Radiopharmaceuticals & Contrast Media market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Diagnostic Radiopharmaceuticals & Contrast Media market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Radiopharmaceuticals
Contrast Media
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Diagnostic Radiopharmaceuticals & Contrast Media market are listed below:
Amag Pharmaceuticals
Bayer Healthcare
Bracco Imaging
Daiichi Sankyo
GE Healthcare
Guerbet
Lantheus
Mallinckrodt
Medtronic
Nordion
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Diagnostic Radiopharmaceuticals & Contrast Media product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, with price, sales, revenue and global market share of Diagnostic Radiopharmaceuticals & Contrast Media from 2019 to 2021.
Chapter 3, the Diagnostic Radiopharmaceuticals & Contrast Media competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diagnostic Radiopharmaceuticals & Contrast Media breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Diagnostic Radiopharmaceuticals & Contrast Media market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Diagnostic Radiopharmaceuticals & Contrast Media sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Diagnostic Radiopharmaceuticals & Contrast Media Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Radiopharmaceuticals
1.2.3 Contrast Media
1.3 Market Analysis by Application
1.3.1 Overview: Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size & Forecast
1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales in Value (2016-2026))
1.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume (2016-2026)
1.4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2016-2026) & (US$/Unit)
1.5 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity Analysis
1.5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Total Production Capacity (2016-2026)
1.5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
1.6.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
1.6.3 Diagnostic Radiopharmaceuticals & Contrast Media Trends Analysis
2 Manufacturers Profiles
2.1 Amag Pharmaceuticals
2.1.1 Amag Pharmaceuticals Details
2.1.2 Amag Pharmaceuticals Major Business
2.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bayer Healthcare
2.2.1 Bayer Healthcare Details
2.2.2 Bayer Healthcare Major Business
2.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bracco Imaging
2.3.1 Bracco Imaging Details
2.3.2 Bracco Imaging Major Business
2.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Daiichi Sankyo
2.4.1 Daiichi Sankyo Details
2.4.2 Daiichi Sankyo Major Business
2.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business
2.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Guerbet
2.6.1 Guerbet Details
2.6.2 Guerbet Major Business
2.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Lantheus
2.7.1 Lantheus Details
2.7.2 Lantheus Major Business
2.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.7.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Mallinckrodt
2.8.1 Mallinckrodt Details
2.8.2 Mallinckrodt Major Business
2.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Medtronic
2.9.1 Medtronic Details
2.9.2 Medtronic Major Business
2.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Nordion
2.10.1 Nordion Details
2.10.2 Nordion Major Business
2.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
2.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Diagnostic Radiopharmaceuticals & Contrast Media Sales by Manufacturer
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Diagnostic Radiopharmaceuticals & Contrast Media
3.4 Market Concentration Rate
3.4.1 Top 3 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer Market Share
3.4.2 Top 6 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer Market Share
3.5 Global Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Diagnostic Radiopharmaceuticals & Contrast Media Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region
4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume by Region (2016-2026)
4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2016-2026)
4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026)
4.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026)
4.4 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026)
4.5 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026)
4.6 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume by Type (2016-2026)
5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2016-2026)
5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume by Application (2016-2026)
6.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2016-2026)
6.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2026)
7.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2026)
7.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
7.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume by Country (2016-2026)
7.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2026)
8.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2026)
8.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
8.3.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume by Country (2016-2026)
8.3.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2026)
9.2 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2026)
9.3 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region
9.3.1 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2026)
10.2 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2026)
10.3 South America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
10.3.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume by Country (2016-2026)
10.3.2 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2026)
11.2 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2026)
11.3 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
11.3.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Diagnostic Radiopharmaceuticals & Contrast Media Typical Distributors
12.3 Diagnostic Radiopharmaceuticals & Contrast Media Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type, (USD Million), 2021-2026
Table 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application, (USD Million), 2021-2026
Table 3. Amag Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Amag Pharmaceuticals Major Business
Table 5. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 6. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Healthcare Major Business
Table 9. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 10. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 12. Bracco Imaging Major Business
Table 13. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 14. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 16. Daiichi Sankyo Major Business
Table 17. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 18. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. GE Healthcare Major Business
Table 21. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 22. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Guerbet Basic Information, Manufacturing Base and Competitors
Table 24. Guerbet Major Business
Table 25. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 26. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Lantheus Basic Information, Manufacturing Base and Competitors
Table 28. Lantheus Major Business
Table 29. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 30. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 32. Mallinckrodt Major Business
Table 33. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 34. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Medtronic Basic Information, Manufacturing Base and Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 38. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Nordion Basic Information, Manufacturing Base and Competitors
Table 40. Nordion Major Business
Table 41. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product and Services
Table 42. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Diagnostic Radiopharmaceuticals & Contrast Media, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Diagnostic Radiopharmaceuticals & Contrast Media Production Site of Key Manufacturer
Table 48. Diagnostic Radiopharmaceuticals & Contrast Media New Entrant and Capacity Expansion Plans
Table 49. Diagnostic Radiopharmaceuticals & Contrast Media Mergers & Acquisitions in the Past Five Years
Table 50. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2016-2021e) & (K Units)
Table 51. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2021-2026) & (K Units)
Table 52. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2021e) & (K Units)
Table 55. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2021-2026) & (K Units)
Table 56. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2016-2021e) & (US$/Unit)
Table 59. Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2021-2026) & (US$/Unit)
Table 60. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2021e) & (K Units)
Table 61. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2021-2026) & (K Units)
Table 62. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2016-2021e) & (US$/Unit)
Table 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2021-2026) & (US$/Unit)
Table 66. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2016-2021e) & (K Units)
Table 67. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2021-2026) & (K Units)
Table 68. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2021e) & (K Units)
Table 71. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2021-2026) & (K Units)
Table 72. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2021e) & (K Units)
Table 73. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2021-2026) & (K Units)
Table 74. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2021-2026) & (K Units)
Table 76. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2021-2026) & (K Units)
Table 80. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2021-2026) & (K Units)
Table 90. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2016-2021e) & (K Units)
Table 91. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2021-2026) & (K Units)
Table 92. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2021e) & (K Units)
Table 95. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2021-2026) & (K Units)
Table 96. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2021e) & (K Units)
Table 97. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Diagnostic Radiopharmaceuticals & Contrast Media Typical Distributors
Table 109. Diagnostic Radiopharmaceuticals & Contrast Media Typical Customers
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals & Contrast Media Picture
Figure 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type in 2020
Figure 3. Radiopharmaceuticals
Figure 4. Contrast Media
Figure 5. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (2016-2026) & (K Units)
Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity (2016-2026) & (K Units)
Figure 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
Figure 16. Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
Figure 17. Diagnostic Radiopharmaceuticals & Contrast Media Market Trends
Figure 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturer in 2020
Figure 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturer in 2020
Figure 20. Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2016-2026)
Figure 24. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2016-2026)
Figure 25. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026) & (USD Million)
Figure 26. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026) & (USD Million)
Figure 28. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2016-2026) & (USD Million)
Figure 30. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2016-2026)
Figure 31. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2016-2026)
Figure 32. Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2016-2026)
Figure 34. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2016-2026)
Figure 35. Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2016-2026)
Figure 37. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2016-2026)
Figure 38. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2016-2026)
Figure 39. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2016-2026)
Figure 40. United States Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2016-2026)
Figure 44. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2016-2026)
Figure 45. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2016-2026)
Figure 46. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2016-2026)
Figure 47. Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2016-2026)
Figure 56. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2016-2026)
Figure 63. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2016-2026)
Figure 64. South America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2016-2026)
Figure 65. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
